Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
3 Healthcare Stocks Getting Help From the Aging Population
12:25pm, Monday, 06'th Nov 2023
A record number of Americans are now turning 65, Forbes recently reported, amid tens of millions of Baby Boomers. In fact, according to one report, 76.4 million Baby Boomers are living in America curr
2 Growth Stocks That Could Help Set You Up for Life
09:57am, Thursday, 02'nd Nov 2023
Healthcare and e-commerce are two massive, lucrative industries that aren't slowing down. DexCom is riding on a wave of profits and cash from its latest launches.
3 Reasons Growth Investors Will Love DexCom (DXCM)
02:18pm, Tuesday, 31'st Oct 2023
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What Makes DexCom (DXCM) a New Buy Stock
01:31pm, Tuesday, 31'st Oct 2023
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Dexcom stock climbs as worries surrounding weight-loss drugs fades
10:04pm, Friday, 27'th Oct 2023
CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector.
Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be
02:52pm, Friday, 27'th Oct 2023
The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.
DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook
09:02am, Friday, 27'th Oct 2023
DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript
07:57pm, Thursday, 26'th Oct 2023
Dexcom, Inc. (NASDAQ:DXCM ) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairm
DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say
07:35pm, Thursday, 26'th Oct 2023
The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates
06:48pm, Thursday, 26'th Oct 2023
DexCom (DXCM) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.28 per share a year ago.
Dexcom Shrugs Off Pressure From Weight-Loss Drugs, Boosts 2023 Outlook. Stock Pops 14%.
04:50pm, Thursday, 26'th Oct 2023
Dexcom topped third-quarter expectations Thursday, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped.
Glucose monitor maker DexCom's stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows
04:48pm, Thursday, 26'th Oct 2023
Shares of DexCom Inc. DXCM, -3.86% shot up 15.3% to pace the S&P 500's SPX, -1.18% after-hours gainers on Thursday, after of maker of glucose monitoring systems reported third-quarter profit that beat
Dexcom lifts 2023 revenue view on strong demand for diabetes devices
04:42pm, Thursday, 26'th Oct 2023
Medical device maker Dexcom on Thursday raised its annual revenue forecast and beat quarterly estimates on strong demand for its continuous glucose monitoring (CGM) devices, sending its shares more th
2 Best Healthcare Stocks to Buy Right Now
09:15am, Thursday, 26'th Oct 2023
The stock market may be volatile, but investors don't have to wait on the sidelines. Vertex Pharmaceuticals is forging its own path in the rare disease drug market.
DexCom (DXCM) to Report Q3 Earnings: Is a Beat in Store?
09:48am, Wednesday, 25'th Oct 2023
DexCom's (DXCM) third-quarter 2023 results are likely to reflect rising volumes across all channels.
